People: Protalix Biotherapeutics Inc (PLX.TA)

PLX.TA on Tel Aviv Stock Exchange

1,163.00
31 Jul 2014
Price Change (% chg)

-13.00₪ (-1.10%)
Prev Close
1,179.00₪
Open
1,179.00₪
Day's High
1,190.00₪
Day's Low
1,163.00₪
Volume
46,078
Avg. Vol
100,072
52-wk High
1,993.00₪
52-wk Low
1,089.00₪

Search Stocks

Lauterbach, Sandra 

Brief Biography

Ms. Sandra L. Lauterbach is Vice President - Sales and Commercial Affairs of Protalix BioTherapeutics Inc., since December 18, 2009. Prior to joining the company, Ms. Lauterbach was the Vice President of Marketing, Endocrinology of EMD Serono, Inc., from July 2008 through July 2009. Prior to that, from August 2003 through July 2008, she served in a number of positions at Genzyme Corporation, the last position being the Senior Director, Global Marketing of Fabrazyme. Ms. Lauterbach holds a B.Sc. in Molecular Biology from the University of Wisconsin—Madison and an MBA from the University of South Florida.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
186,410 -- 467,810 654,220

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Shlomo Yanai

--

David Aviezer

3,230,140

Yossi Maimon

1,389,600

Tzvi Palash

669,029

Yoseph Shaaltiel

1,594,580

Einat Almon

1,436,370
As Of 30 Dec 2012
Search Stocks